Neurol. praxi. 2015;16(2):74-76

Treating epilepsy and epilepsy syndromes in children

doc. MUDr. Pavol Sýkora, CSc.
Klinika detskej neurológie LF UK a DFNsP, Bratislava

Epilepsy is a chronic brain disease characterized by seizures and a persistent predisposition to developing them as well as by neurobiological, cognitive, and psychosocial consequences of this condition. Epilepsy is not a nosological entity; it is a group of conditions with varying aetiology, clinical presentation, course, and treatment. The goal of antiepileptic treatment is to achieve a seizure-free state, without affecting mental and physical performance. Treatment is predominantly pharmacological, using antiepileptics. The choice of an antiepileptic drug depends on the type of seizures, but in particular on the type of epilepsy or epilepsy syndrome. The majority of patients achieve a seizure-free state or a significant reduction in seizures. The article presents the current treatment options for epilepsy and epilepsy syndromes in children. In 20 to 30 percent of patients, pharmacological treatment fails and the epilepsy is pharmacoresistant. The treatment options for pharmacoresistant epilepsy include epilepsy surgery, vagus nerve stimulation, or ketogenic diet. Despite major progress in the diagnosis and treatment, epilepsy continues to be a serious medical and social issue.

Keywords: epilepsy treatment, pharmacotherapy, antiepileptics, pharmacoresistance, epilepsy surgery, ketogenic diet, vagus nerve stimulation

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sýkora P. Treating epilepsy and epilepsy syndromes in children. Neurol. praxi. 2015;16(2):74-76.
Download citation

References

  1. Commision on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981; 22: 489-501. Go to original source... Go to PubMed...
  2. Commision on Classification and Teminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989; 30: 389-399. Go to original source... Go to PubMed...
  3. Donáth V, Kuchar M, Sýkora P. Epilepsia - praktická príručka diagnostiky a liečby. Bratislava: SPN, 2000: 340.
  4. Komárek V. Epileptické záchvaty a syndrómy. Praha: Galén, 1997: 177.
  5. Kolníkova M, Sýkora P. Ketogénna diéta - alternatívna liečba farmakorezistentnej epilepsie. Neurol. prax. 2005; 3: 154-156.
  6. Kwan P, Arzimanoglou A, Berg TA, Brodie MJ, Allen HW, Methern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51(6): 1069-1077. Go to original source... Go to PubMed...
  7. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51(6): 1069-1077. Go to original source... Go to PubMed...
  8. Meador KJ, Baker GA, Browning N, Cohen, MJ, Bromley JL, Clayton-Smith L, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. For the NEAD Study Group. Effects of fetal antiepileptic drug exposure. Neurology. 2012; 78: 1207-1214. Go to original source... Go to PubMed...
  9. Panayiotopoulos CP. A clinical guide to epileptic syndromes and their treatment. London: Springer-Verlag, 2007: 578.
  10. Roger J, Bureau M, Dravet CH, Dreifuss FE, Perret A, Wolf P. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed. John Libbey, 1992: 572.
  11. Roger J, Bureau M, Dravet CH, Genton P, Tassinari CA, Wolf P. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. John Libbey, 2002: 544.
  12. Sýkora P, Payerová J, Brozmanová M, Mego R, Hricáková J. Epileptické záchvaty, epilepsie a epileptické syndrómy v detskom a adolescentnom veku. Čes a slov Neurol. Neurochir. 2000; 63(93): 102-109.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.